Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
miRNA signatures in Sera of patients with active pulmonary tuberculosis
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2331847
Author(s) Miotto, Paolo; Mwangoka, Grace; Valente, Ilaria C.; Norbis, Luca; Sotgiu, Giovanni; Bosu, Roberta; Ambrosi, Alessandro; Codecasa, Luigi R.; Goletti, Delia; Matteelli, Alberto; Ntinginya, Elias N.; Aloi, Francesco; Heinrich, Norbert; Reither, Klaus; Cirillo, Daniela M.
Author(s) at UniBasel Reither, Klaus
Year 2013
Title miRNA signatures in Sera of patients with active pulmonary tuberculosis
Journal PLoS ONE
Volume 8
Number 11
Pages / Article-Number e80149
Mesh terms Adult; Aged; Aged, 80 and over; Female; Humans; Logistic Models; Male; MicroRNAs, blood; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Support Vector Machine; Tuberculosis, Pulmonary, blood; Young Adult
Abstract Several studies showed that assessing levels of specific circulating microRNAs (miRNAs) is a non-invasive, rapid, and accurate method for diagnosing diseases or detecting alterations in physiological conditions. We aimed to identify a serum miRNA signature to be used for the diagnosis of tuberculosis (TB). To account for variations due to the genetic makeup, we enrolled adults from two study settings in Europe and Africa. The following categories of subjects were considered: healthy (H), active pulmonary TB (PTB), active pulmonary TB, HIV co-infected (PTB/HIV), latent TB infection (LTBI), other pulmonary infections (OPI), and active extra-pulmonary TB (EPTB). Sera from 10 subjects of the same category were pooled and, after total RNA extraction, screened for miRNA levels by TaqMan low-density arrays. After identification of "relevant miRNAs", we refined the serum miRNA signature discriminating between H and PTB on individual subjects. Signatures were analyzed for their diagnostic performances using a multivariate logistic model and a Relevance Vector Machine (RVM) model. A leave-one-out-cross-validation (LOOCV) approach was adopted for assessing how both models could perform in practice. The analysis on pooled specimens identified selected miRNAs as discriminatory for the categories analyzed. On individual serum samples, we showed that 15 miRNAs serve as signature for H and PTB categories with a diagnostic accuracy of 82% (CI 70.2-90.0), and 77% (CI 64.2-85.9) in a RVM and a logistic classification model, respectively. Considering the different ethnicity, by selecting the specific signature for the European group (10 miRNAs) the diagnostic accuracy increased up to 83% (CI 68.1-92.1), and 81% (65.0-90.3), respectively. The African-specific signature (12 miRNAs) increased the diagnostic accuracy up to 95% (CI 76.4-99.1), and 100% (83.9-100.0), respectively. Serum miRNA signatures represent an interesting source of biomarkers for TB disease with the potential to discriminate between PTB and LTBI, but also among the other categories.
Publisher Public Library of Science
ISSN/ISBN 1932-6203
edoc-URL http://edoc.unibas.ch/dok/A6212271
Full Text on edoc Available
Digital Object Identifier DOI 10.1371/journal.pone.0080149
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/24278252
ISI-Number WOS:000327539800058
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.353 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
12/05/2024